Whole Genome Analysis of African G12P[6] and G12P[8] Rotaviruses Provides Evidence of Porcine-Human Reassortment at NSP2, NSP3, and NSP4.

Africa genotype 12 group A rotaviruses next generation sequencing reassortment whole genome sequencing

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2020
Historique:
received: 09 09 2020
accepted: 10 12 2020
entrez: 29 1 2021
pubmed: 30 1 2021
medline: 30 1 2021
Statut: epublish

Résumé

Group A rotaviruses (RVA) represent the most common cause of pediatric gastroenteritis in children <5 years, worldwide. There has been an increase in global detection and reported cases of acute gastroenteritis caused by RVA genotype G12 strains, particularly in Africa. This study sought to characterize the genomic relationship between African G12 strains and determine the possible origin of these strains. Whole genome sequencing of 34 RVA G12P[6] and G12P[8] strains detected from the continent including southern (South Africa, Zambia, Zimbabwe), eastern (Ethiopia, Uganda), central (Cameroon), and western (Togo) African regions, were sequenced using the Ion Torrent PGM method. The majority of the strains possessed a Wa-like backbone with consensus genotype constellation of G12-P[6]/P[8]-I1-R1-C1-M1-A1-N1-T1-E1-H1, while a single strain from Ethiopia displayed a DS-1-like genetic constellation of G12-P[6]-I2-R2-C2-M2-A2-N2-T2-E2-H2. In addition, three Ethiopian and one South African strains exhibited a genotype 2 reassortment of the NSP3 gene, with genetic constellation of G12-P[8]-I1-R1-C1-M1-A1-N1-T2-E1-H1. Overall, 10 gene segments (VP1-VP4, VP6, and NSP1-NSP5) of African G12 strains were determined to be genetically related to cognate gene sequences from globally circulating human Wa-like G12, G9, and G1 strains with nucleotide (amino acid) identities in the range of 94.1-99.9% (96.5-100%), 88.5-98.5% (93-99.1%), and 89.8-99.0% (88.7-100%), respectively. Phylogenetic analysis showed that the Ethiopian G12P[6] possessing a DS-1-like backbone consistently clustered with G2P[4] strains from Senegal and G3P[6] from Ethiopia with the VP1, VP2, VP6, and NSP1-NSP4 genes. Notably, the NSP2, NSP3, and NSP4 of most of the study strains exhibited the closest relationship with porcine strains suggesting the occurrence of reassortment between human and porcine strains. Our results add to the understanding of potential roles that interspecies transmission play in generating human rotavirus diversity through reassortment events and provide insights into the evolutionary dynamics of G12 strains spreading across selected sub-Saharan Africa regions.

Identifiants

pubmed: 33510725
doi: 10.3389/fmicb.2020.604444
pmc: PMC7835662
doi:

Types de publication

Journal Article

Langues

eng

Pagination

604444

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2021 Mokoena, Esona, Seheri, Nyaga, Magagula, Mukaratirwa, Mulindwa, Abebe, Boula, Tsolenyanu, Simwaka, Rakau, Peenze, Mwenda, Mphahlele and Steele.

Déclaration de conflit d'intérêts

AS was employed by the Bill & Melinda Gates Foundation which is working on rotavirus vaccine development and deployment. Understanding rotavirus strain diversity and evolution, including under possible vaccine pressure, is an important goal. The Bill & Melinda Gates Foundation partially funded the African Enteric Viruses Genome Initiative (AEVGI) at the University of Free State, but was not involved in sample selection or the laboratory methodology used. AS was engaged in the interpretation of the data and the drafting and approval of the manuscript as the senior corresponding author. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Med Virol. 2011 Nov;83(11):2018-42
pubmed: 21915879
PLoS One. 2017 Jun 22;12(6):e0178855
pubmed: 28640820
Infect Genet Evol. 2015 Apr;31:321-34
pubmed: 25701122
J Med Virol. 2015 Jan;87(1):79-101
pubmed: 24841697
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
BMC Res Notes. 2018 Jan 5;11(1):5
pubmed: 29304830
Infect Genet Evol. 2015 Oct;35:34-7
pubmed: 26205691
Arch Virol. 2017 Jan;162(1):213-226
pubmed: 27718073
New Microbes New Infect. 2015 Apr 20;6:30-2
pubmed: 26082841
J Med Microbiol. 2017 Feb;66(2):112-118
pubmed: 28051950
Mol Biol Evol. 2010 Oct;27(10):2431-6
pubmed: 20522727
Future Microbiol. 2011 Sep;6(9):1049-65
pubmed: 21958144
J Virol. 2008 Apr;82(7):3204-19
pubmed: 18216098
J Clin Virol. 2006 Jul;36(3):183-8
pubmed: 16679056
J Virol. 1990 Nov;64(11):5640-4
pubmed: 2170690
Curr Opin Virol. 2012 Aug;2(4):426-33
pubmed: 22683209
J Med Virol. 2013 Aug;85(8):1485-90
pubmed: 23765785
Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S76-84
pubmed: 24343619
Emerg Infect Dis. 2009 Jan;15(1):87-90
pubmed: 19116060
Infect Genet Evol. 2014 Dec;28:385-8
pubmed: 24747965
J Clin Microbiol. 2003 Dec;41(12):5764-9
pubmed: 14662978
PLoS One. 2014 Jun 26;9(6):e100953
pubmed: 24968018
Clin Lab Med. 2015 Jun;35(2):363-91
pubmed: 26004648
Rev Med Virol. 2005 Jan-Feb;15(1):29-56
pubmed: 15484186
Arch Virol. 2011 Aug;156(8):1397-413
pubmed: 21597953
J Virol. 2007 Mar;81(5):2382-90
pubmed: 17166908
J Med Virol. 2018 Feb;90(2):239-249
pubmed: 28906005
PLoS One. 2014 Oct 20;9(10):e110795
pubmed: 25330070
Vaccine. 2018 Nov 12;36(47):7222-7230
pubmed: 29203181
J Infect Dis. 2010 Sep 1;202 Suppl:S5-S11
pubmed: 20684718
Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S41-4
pubmed: 24343612
Pediatr Infect Dis J. 2014 Apr;33(4):355-9
pubmed: 24637513
PLoS One. 2015 May 04;10(5):e0124965
pubmed: 25938434
Acta Microbiol Immunol Hung. 2013 Mar;60(1):21-8
pubmed: 23529296
J Med Virol. 2015 Aug;87(8):1292-302
pubmed: 25758365
Vaccine. 2012 Apr 27;30 Suppl 1:A122-30
pubmed: 22520121
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
Future Microbiol. 2009 Dec;4(10):1303-16
pubmed: 19995190
J Clin Microbiol. 2002 Apr;40(4):1390-4
pubmed: 11923362
Vaccine. 2012 Apr 27;30 Suppl 1:A140-51
pubmed: 22520123
Virus Genes. 2014 Oct;49(2):196-207
pubmed: 24952422
Virus Res. 2016 Sep 15;224:38-45
pubmed: 27565028
J Med Virol. 2009 Jan;81(1):106-13
pubmed: 19031449
Infect Genet Evol. 2014 Dec;28:446-61
pubmed: 25224179
Infect Genet Evol. 2013 Jun;16:62-77
pubmed: 23369762
J Gen Virol. 2019 Jun;100(6):932-937
pubmed: 31140967
Vaccine. 2018 Nov 12;36(46):7043-7047
pubmed: 30301641
JAMA Pediatr. 2018 Oct 1;172(10):958-965
pubmed: 30105384
Emerg Infect Dis. 2009 Sep;15(9):1512-5
pubmed: 19788829
Infect Genet Evol. 2014 Oct;27:277-93
pubmed: 25111611
Arch Virol. 2018 Jan;163(1):153-165
pubmed: 29052059
Arch Virol. 1990;113(3-4):279-82
pubmed: 2171461
Vet Microbiol. 2012 May 4;156(3-4):238-45
pubmed: 22079216
BMC Microbiol. 2009 Nov 23;9:238
pubmed: 19930627

Auteurs

Fortunate Mokoena (F)

Department of Biochemistry, Faculty of Natural and Agricultural Science, North West University, Mmabatho, South Africa.
Diarrhoeal Pathogens Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Mathew Dioh Esona (MD)

Diarrhoeal Pathogens Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Luyanda Mapaseka Seheri (LM)

Diarrhoeal Pathogens Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Martin Munene Nyaga (MM)

Next Generation Sequencing Unit and Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.

Nonkululelo Bonakele Magagula (NB)

Diarrhoeal Pathogens Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Arnold Mukaratirwa (A)

Department of Medical Microbiology, University of Zimbabwe-College of Health Sciences, Harare, Zimbabwe.

Augustine Mulindwa (A)

Mulago National Referral Hospital, Kampala, Uganda.

Almaz Abebe (A)

Ethiopian Public Health Institute, Addis Ababa, Ethiopia.

Angeline Boula (A)

Mother and Child Center, Chantal Biya Foundation, Yaoundé, Cameroon.

Enyonam Tsolenyanu (E)

Department of Paediatrics, Sylvanus Olympio Teaching Hospital of Lome, Lome, Togo.

Julia Simwaka (J)

Virology Laboratory, University Teaching Hospital, Lusaka, Zambia.

Kebareng Giliking Rakau (KG)

Diarrhoeal Pathogens Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Ina Peenze (I)

Diarrhoeal Pathogens Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Jason Mathiu Mwenda (JM)

African Rotavirus Surveillance Network, Immunization, Vaccines and Development Cluster, WHO African Regional Office, Brazzaville, Congo.

Maphahlaganye Jeffrey Mphahlele (MJ)

Diarrhoeal Pathogens Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Andrew Duncan Steele (AD)

Diarrhoeal Pathogens Research Unit, Department of Virology, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, WA, United States.

Classifications MeSH